칸나비디올(CBD) 시장 규모, 점유율, 성장률 및 세계 산업 분석 : 유형 및 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of cannabidiol (CBD) Market

The global cannabidiol (CBD) market is witnessing unprecedented growth, driven by rising consumer awareness of its health benefits, increased legalization, and growing adoption across multiple industries. According to the latest report by Fortunebusinessinsights.com, the market size was valued at USD 16.52 billion in 2025 and is projected to grow to USD 24.61 billion in 2026, ultimately reaching USD 382.04 billion by 2034, registering a remarkable CAGR of 40.89% during the forecast period of 2026-2034.

Market Drivers and Growth Factors

CBD is primarily extracted from hemp due to its naturally high cannabidiol content, although it can also be derived from marijuana. Unlike tetrahydrocannabinol (THC), CBD is non-psychoactive, offering several therapeutic benefits including anxiety relief, anti-inflammatory properties, seizure prevention, and pain reduction. The surge in demand is further fueled by its incorporation into the pharmaceutical, cosmetics, and food industries.

Manufacturers are increasingly focusing on innovative product formulations to cater to evolving consumer preferences. For instance, British Cannabis acquired Goodbody Botanicals Ltd in February 2024 to expand its CBD-infused wellness and cosmetics portfolio globally. Moreover, the COVID-19 pandemic initially impacted market growth due to lockdowns and reduced food and beverage operations, but post-pandemic recovery is expected to support robust growth.

Market Segmentation

By Source:

The marijuana-derived CBD segment dominated in 2026, expected to account for 56.07% of the market, benefiting from greater availability and legalization in North America and Europe. Hemp-derived CBD is also gaining traction, particularly in health and wellness products.

By Application:

The pharmaceutical sector remains the largest consumer of CBD products due to its therapeutic benefits. In 2026, the pharmaceutical segment is projected to account for 36.9% of the global market, with significant applications in pain relief, neuroprotection, and inflammation management. The food and beverage sector is also increasingly adopting CBD for fortified and health-focused products.

Regional Insights

North America:

The region dominated the global CBD market in 2025 with 47.63% market share, representing USD 7.87 billion, and is projected to reach USD 11.8 billion in 2026. The U.S. market is expected to grow to USD 78.74 billion by 2032, driven by liberalized regulations and growing consumer acceptance. Canada is also witnessing steady growth through legal reforms and product diversification.

Europe:

Europe held 25.52% of the market in 2025, valued at USD 4.22 billion, and is expected to reach USD 6.28 billion in 2026. Key markets include the UK (USD 1.76 billion in 2026) and Germany (USD 1.19 billion in 2026), with growing demand for smoking, vaping, and edible CBD products.

Asia Pacific:

The market in Asia Pacific reached USD 2.88 billion in 2025 (17.47% share) and is projected to grow to USD 4.28 billion in 2026, driven by regulatory changes in countries like China, Japan, India, and Thailand. Thailand legalized medical cannabis and hemp usage, positioning it as a regional growth hub.

South America, Middle East & Africa, and Latin America:

South America is expanding through legal reforms, with Uruguay, Peru, and Colombia leading medicinal cannabis adoption. Middle East & Africa contributed USD 0.65 billion in 2025, with slower growth due to restrictions in UAE and Saudi Arabia, though Lebanon and South Africa show promising developments. Latin America generated USD 0.9 billion in 2025, expected to reach USD 1.32 billion in 2026.

Key Market Trends

1. Health & Fitness: Consumers increasingly prefer CBD-infused products for wellness, anti-inflammatory benefits, and overall health maintenance. BASF SE launched ComfortBD, a certified organic CBD skincare product, targeting red and irritated skin in August 2022.

2. Government Approvals: Regulatory acceptance, particularly by the U.S. FDA, facilitates CBD incorporation in food, pharma, and other applications.

3. Mergers and Acquisitions: Strategic acquisitions like British Cannabis' 2024 acquisition of Goodbody Botanicals Ltd expand product portfolios and market presence.

Major Players

Leading CBD companies focus on product innovation, R&D, and distribution to consolidate market share. Key players include:

• Medical Marijuana Inc. (California, U.S.)
• Medterra CBD (California, U.S.)
• Aurora Cannabis Inc. (Edmonton, Canada)
• ENDOCA (Chicago, U.S.)
• Folium Biosciences (Texas, U.S.)

Conclusion

The global cannabidiol market demonstrates enormous growth potential across pharmaceuticals, cosmetics, and food sectors, propelled by regulatory support, rising consumer awareness, and innovative product offerings. With a projected market value of USD 382.04 billion by 2034, CBD is poised to become a mainstream health and wellness commodity globally.

Segmentation By Source

• Marijuana
• Hemp

By Application

• Pharmaceuticals
• Food and Beverages
• Pet Care
• Cosmetics
• Others

By Region

• North America (By Source, Application, and By Country)
  • The U.S. (By Source)
  • Canada (By Source)
  • Mexico (By Source)
• Europe (By Source, Application, and By Country)
  • Russia (By Source)
  • Austria (By Source)
  • Italy (By Source)
  • Germany (By Source)
  • U.K. (By Source)
  • Rest of Europe (Source)
• Asia Pacific (By Source, Application, and By Country)
  • China (By Source)
  • Australia (By Source)
  • India (By Source)
  • Japan (By Source)
  • Rest of Asia Pacific (By Source)
• South America (By Source, Application, and By Country)
  • Argentina (By Source)
  • Brazil (By Source)
  • Rest of South America (By Source)
• The Middle East and Africa (By Source, Application, and By Country)
  • South Africa (By Source)
  • UAE (By Source)
  • Rest of ME&A (By Source)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Emerging Trends

4. Key Insights

• 4.1. Overview on Cannabis Markets
• 4.2. Supply Chain and Industry SWOT Analysis
• 4.3. Global Cannabidiol Regulatory Analysis
• 4.4. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches
• 4.5. Impact of COVID-19
  • 4.5.1. Challenges in Supply Chain
  • 4.5.2. Efforts to Mitigate the Challenges

5. Global Cannabidiol Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Size Estimates and Forecast
  • 5.2.1. By Source
    • 5.2.1.1. Marijuana
    • 5.2.1.2. Hemp
  • 5.2.2. By Application
    • 5.2.2.1. Food & Beverages
    • 5.2.2.2. Pharmaceuticals
    • 5.2.2.3. Pet Care
    • 5.2.2.4. Cosmetics
    • 5.2.2.5. Others
  • 5.2.3. By Region
    • 5.2.3.1. North America
    • 5.2.3.2. Europe
    • 5.2.3.3. Asia Pacific
    • 5.2.3.4. South America
    • 5.2.3.5. Middle East & Africa

6. North America Cannabidiol Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Size Estimates and Forecast
  • 6.2.1. By Source
    • 6.2.1.1. Marijuana
    • 6.2.1.2. Hemp
  • 6.2.2. By Application
    • 6.2.2.1. Food & Beverages
    • 6.2.2.2. Pharmaceuticals
    • 6.2.2.3. Pet Care
    • 6.2.2.4. Cosmetics
    • 6.2.2.5. Others
  • 6.2.3. By Country (Value)
    • 6.2.3.1. U.S
      • 6.2.3.1.1. By Source (Value)
        • 6.2.3.1.1.1. Marijuana
        • 6.2.3.1.1.2. Hemp
    • 6.2.3.2. Canada
      • 6.2.3.2.1. By Source (Value)
        • 6.2.3.2.1.1. Marijuana
        • 6.2.3.2.1.2. Hemp

7. Europe Cannabidiol Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Size Estimates and Forecast
  • 7.2.1. By Source
    • 7.2.1.1. Marijuana
    • 7.2.1.2. Hemp
  • 7.2.2. By Application
    • 7.2.2.1. Food & Beverages
    • 7.2.2.2. Pharmaceuticals
    • 7.2.2.3. Pet Care
    • 7.2.2.4. Cosmetics
    • 7.2.2.5. Others
  • 7.2.3. By Country (Value)
    • 7.2.3.1. Russia
      • 7.2.3.1.1. By Source (Value)
        • 7.2.3.1.1.1. Marijuana
        • 7.2.3.1.1.2. Hemp
    • 7.2.3.2. Austria
      • 7.2.3.2.1. By Source (Value)
        • 7.2.3.2.1.1. Marijuana
        • 7.2.3.2.1.2. Hemp
    • 7.2.3.3. Italy
      • 7.2.3.3.1. By Source (Value)
        • 7.2.3.3.1.1. Marijuana
        • 7.2.3.3.1.2. Hemp
    • 7.2.3.4. Germany
      • 7.2.3.4.1. By Source (Value)
        • 7.2.3.4.1.1. Marijuana
        • 7.2.3.4.1.2. Hemp
    • 7.2.3.5. U.K.
      • 7.2.3.5.1. By Source (Value)
        • 7.2.3.5.1.1. Marijuana
        • 7.2.3.5.1.2. Hemp
    • 7.2.3.6. Rest of Europe
      • 7.2.3.6.1. By Source (Value)
        • 7.2.3.6.1.1. Marijuana
        • 7.2.3.6.1.2. Hemp

8. Asia Pacific Cannabidiol Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Size Estimates and Forecast
  • 8.2.1. By Source
    • 8.2.1.1. Marijuana
    • 8.2.1.2. Hemp
  • 8.2.2. By Application
    • 8.2.2.1. Food & Beverages
    • 8.2.2.2. Pharmaceuticals
    • 8.2.2.3. Pet Care
    • 8.2.2.4. Cosmetics
    • 8.2.2.5. Others
  • 8.2.3. By Country (Value)
    • 8.2.3.1. China
      • 8.2.3.1.1. By Source (Value)
        • 8.2.3.1.1.1. Marijuana
        • 8.2.3.1.1.2. Hemp
    • 8.2.3.2. Australia
      • 8.2.3.2.1. By Source (Value)
        • 8.2.3.2.1.1. Marijuana
        • 8.2.3.2.1.2. Hemp
    • 8.2.3.3. India
      • 8.2.3.3.1. By Source (Value)
        • 8.2.3.3.1.1. Marijuana
        • 8.2.3.3.1.2. Hemp
    • 8.2.3.4. Japan
      • 8.2.3.4.1. By Source (Value)
        • 8.2.3.4.1.1. Marijuana
        • 8.2.3.4.1.2. Hemp
    • 8.2.3.5. Rest of APAC
      • 8.2.3.5.1. By Source (Value)
        • 8.2.3.5.1.1. Marijuana
        • 8.2.3.5.1.2. Hemp

9. South America Cannabidiol Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Size Estimates and Forecast
  • 9.2.1. By Source
    • 9.2.1.1. Marijuana
    • 9.2.1.2. Hemp
  • 9.2.2. By Application
    • 9.2.2.1. Food & Beverages
    • 9.2.2.2. Pharmaceuticals
    • 9.2.2.3. Pet Care
    • 9.2.2.4. Cosmetics
    • 9.2.2.5. Others
  • 9.2.3. By Country (Value)
    • 9.2.3.1. Argentina
      • 9.2.3.1.1. By Source (Value)
        • 9.2.3.1.1.1. Marijuana
        • 9.2.3.1.1.2. Hemp
    • 9.2.3.2. Brazil
      • 9.2.3.2.1. By Source (Value)
        • 9.2.3.2.1.1. Marijuana
        • 9.2.3.2.1.2. Hemp
    • 9.2.3.3. Rest of South America
      • 9.2.3.3.1. By Source (Value)
        • 9.2.3.3.1.1. Marijuana
        • 9.2.3.3.1.2. Hemp

10. Middle East & Africa Cannabidiol Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Size Estimates and Forecast
  • 10.2.1. By Source
    • 10.2.1.1. Marijuana
    • 10.2.1.2. Hemp
  • 10.2.2. By Application
    • 10.2.2.1. Food & Beverages
    • 10.2.2.2. Pharmaceuticals
    • 10.2.2.3. Pet Care
    • 10.2.2.4. Cosmetics
    • 10.2.2.5. Others
  • 10.2.3. By Country (Value)
    • 10.2.3.1. South Africa
      • 10.2.3.1.1. By Source (Value)
        • 10.2.3.1.1.1. Marijuana
        • 10.2.3.1.1.2. Hemp
    • 10.2.3.2. UAE
      • 10.2.3.2.1. By Source (Value)
        • 10.2.3.2.1.1. Marijuana
        • 10.2.3.2.1.2. Hemp
    • 10.2.3.3. Rest of ME&A
      • 10.2.3.3.1. By Source (Value)
        • 10.2.3.3.1.1. Marijuana

11. Competitive Matrix

• 11.1. Business Strategies Adopted by Leading Players
• 11.2. Global Cannabidiol Market Revenue Share/Ranking Analysis, By Key Manufacturer

12. Company Profiles

• 12.1. Medical Marijuana Inc.
  • 12.1.1. Overview
  • 12.1.2. Description
  • 12.1.3. Source Portfolio
  • 12.1.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.1.5. Recent Developments
• 12.2. Cannoid LLC
  • 12.2.1. Overview
  • 12.2.2. Description
  • 12.2.3. Source Portfolio
  • 12.2.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.2.5. Recent Developments
• 12.3. Isodiol International Inc.
  • 12.3.1. Overview
  • 12.3.2. Description
  • 12.3.3. Source Portfolio
  • 12.3.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.3.5. Recent Developments
• 12.4. Folium Biosciences
  • 12.4.1. Overview
  • 12.4.2. Description
  • 12.4.3. Source Portfolio
  • 12.4.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.4.5. Recent Developments
• 12.5. Aurora Cannabis, Inc.
  • 12.5.1. Overview
  • 12.5.2. Description
  • 12.5.3. Source Portfolio
  • 12.5.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.5.5. Recent Developments
• 12.6. Acqua Minerale San Benedetto SpA
  • 12.6.1. Overview
  • 12.6.2. Description
  • 12.6.3. Source Portfolio
  • 12.6.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.6.5. Recent Developments
• 12.7. Pharmahemp d.o.o
  • 12.7.1. Overview
  • 12.7.2. Description
  • 12.7.3. Source Portfolio
  • 12.7.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.7.5. Recent Developments
• 12.8. ENDOCA
  • 12.8.1. Overview
  • 12.8.2. Description
  • 12.8.3. Source Portfolio
  • 12.8.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.8.5. Recent Developments
• 12.9. Elixinol LLC.
  • 12.9.1. Overview
  • 12.9.2. Description
  • 12.9.3. Source Portfolio
  • 12.9.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.9.5. Recent Developments
• 12.10. CV Sciences
  • 12.10.1. Overview
  • 12.10.2. Description
  • 12.10.3. Source Portfolio
  • 12.10.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.10.5. Recent Developments

13. Strategic Recommendations

14. Appendix